药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Calusterone
Fazadinium bromide
The risk or severity of adverse effects can be increased when Nabiximols is combined with Fazadinium bromide.
Calusterone
Cyclobarbital
The risk or severity of adverse effects can be increased when Nabiximols is combined with Cyclobarbital.
Calusterone
Methylpentynol
The risk or severity of adverse effects can be increased when Nabiximols is combined with Methylpentynol.
Calusterone
Vinyl ether
The risk or severity of adverse effects can be increased when Nabiximols is combined with Vinyl ether.
Calusterone
Niaprazine
The risk or severity of adverse effects can be increased when Nabiximols is combined with Niaprazine.
Calusterone
Mosapramine
The risk or severity of adverse effects can be increased when Nabiximols is combined with Mosapramine.
Calusterone
Fluanisone
The risk or severity of adverse effects can be increased when Nabiximols is combined with Fluanisone.
Calusterone
Hexapropymate
The risk or severity of adverse effects can be increased when Nabiximols is combined with Hexapropymate.
Calusterone
Alcuronium
The risk or severity of adverse effects can be increased when Nabiximols is combined with Alcuronium.
Calusterone
Loprazolam
The risk or severity of adverse effects can be increased when Nabiximols is combined with Loprazolam.
Calusterone
Pridinol
The risk or severity of adverse effects can be increased when Nabiximols is combined with Pridinol.
Calusterone
Fabomotizole
The risk or severity of adverse effects can be increased when Nabiximols is combined with Fabomotizole.
Calusterone
Phenazocine
The risk or severity of adverse effects can be increased when Nabiximols is combined with Phenazocine.
Calusterone
Phenoperidine
The risk or severity of adverse effects can be increased when Nabiximols is combined with Phenoperidine.
Calusterone
Oxiracetam
The risk or severity of adverse effects can be increased when Nabiximols is combined with Oxiracetam.
Calusterone
Diethyl ether
The risk or severity of adverse effects can be increased when Nabiximols is combined with Diethyl ether.
Calusterone
Naftidrofuryl
The risk or severity of adverse effects can be increased when Nabiximols is combined with Naftidrofuryl.
Calusterone
Gallamine
The risk or severity of adverse effects can be increased when Nabiximols is combined with Gallamine.
Calusterone
Allobarbital
The risk or severity of adverse effects can be increased when Nabiximols is combined with Allobarbital.
Calusterone
Emylcamate
The risk or severity of adverse effects can be increased when Nabiximols is combined with Emylcamate.